Coat's-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implant.
OBJECTIVE
Role of intravitreal injection of dexamethasone implant (Ozurdex) for refractory macular thickening.


METHODS
A case report of a 13-year-old boy with Rhodopsin-positive, CRB1-negative retinitis pigmentosa presenting with Coat's-like exudative vitreoretinopathy and treatment-resistant cystoid macular oedema.


RESULTS
A reduction in the macular thickening following a single injection of Ozurdex.


CONCLUSIONS
We present our experience in successful treatment of refractory macular oedema with intravitreal injection of dexamethasone implant resulting in clinically significant resolution of macular thickening.
Eye Unit, Southampton General Hospital, Southampton, UK.
L
L
Patil
1] Eye Unit, Southampton General Hospital, Southampton, UK [2] Faculty of Medicine, Academic Unit of Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
A J
AJ
Lotery
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage*; D004343:Drug Implants; D005122:Exudates and Transudates; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D012174:Retinitis Pigmentosa / Q000150:complications*; D012243:Rhodopsin / Q000378:metabolism*; D016896:Treatment Outcome; D018630:Vitreoretinopathy, Proliferative / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D004343:Drug Implants; D003907:Dexamethasone; D012243:Rhodopsin